| John Robert Coleman, MD | |
|
1204 W Main St, Charlottesville, VA 22903-2824 | |
| (434) 982-6100 | |
| (434) 982-0747 |
| Full Name | John Robert Coleman |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 7 Years |
| Location | 1204 W Main St, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316478258 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | 0101272076 (Virginia) | Primary |
| 207L00000X | Anesthesiology | ML60754900 (Washington) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverside Tappahannock Hospital | Tappahannock, VA | Hospital |
| Medical College Of Virginia Hospitals | Richmond, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcv Associated Physicians | 4385542117 | 1312 |
News Archive
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, editor Amie Newman, a communications officer at the foundation, highlights the work of "two HIV home-visit health workers who work with the CDC Kenya (Centers for Disease Control) to visit with a family in a remote area in the Nyanza province."
The RAND Corporation today launched an online tool to provide policymakers and interested parties with a unique way of understanding and evaluating the effects and unintended consequences of health care reform proposals certain to be introduced in the new 111th Congress and beyond.
Ethicon, Inc., announced today that it has completed the acquisition of Acclarent, Inc., following clearance under the Hart-Scott-Rodino Antitrust Improvement Act. Acclarent is a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT).
A multicenter team of researchers has identified a panel of proteins linked to early development of pancreatic cancer in mice that applies also to early stages of the disease in humans - a breakthrough that brings scientists a significant step closer to developing a blood test to detect the disease early, when cure rates are highest.
EUREKA project E! 3172 NKSTIM has produced a new potential drug to stimulate cancer patients' own 'natural killer' cells to attack and eliminate cancer cells; currently undergoing clinical testing in patients with leukaemia or myeloma.
› Verified 2 days ago
| Entity Name | Mcv Associated Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710959457 PECOS PAC ID: 4385542117 Enrollment ID: O20031230000559 |
News Archive
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, editor Amie Newman, a communications officer at the foundation, highlights the work of "two HIV home-visit health workers who work with the CDC Kenya (Centers for Disease Control) to visit with a family in a remote area in the Nyanza province."
The RAND Corporation today launched an online tool to provide policymakers and interested parties with a unique way of understanding and evaluating the effects and unintended consequences of health care reform proposals certain to be introduced in the new 111th Congress and beyond.
Ethicon, Inc., announced today that it has completed the acquisition of Acclarent, Inc., following clearance under the Hart-Scott-Rodino Antitrust Improvement Act. Acclarent is a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT).
A multicenter team of researchers has identified a panel of proteins linked to early development of pancreatic cancer in mice that applies also to early stages of the disease in humans - a breakthrough that brings scientists a significant step closer to developing a blood test to detect the disease early, when cure rates are highest.
EUREKA project E! 3172 NKSTIM has produced a new potential drug to stimulate cancer patients' own 'natural killer' cells to attack and eliminate cancer cells; currently undergoing clinical testing in patients with leukaemia or myeloma.
› Verified 2 days ago
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, editor Amie Newman, a communications officer at the foundation, highlights the work of "two HIV home-visit health workers who work with the CDC Kenya (Centers for Disease Control) to visit with a family in a remote area in the Nyanza province."
The RAND Corporation today launched an online tool to provide policymakers and interested parties with a unique way of understanding and evaluating the effects and unintended consequences of health care reform proposals certain to be introduced in the new 111th Congress and beyond.
Ethicon, Inc., announced today that it has completed the acquisition of Acclarent, Inc., following clearance under the Hart-Scott-Rodino Antitrust Improvement Act. Acclarent is a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT).
A multicenter team of researchers has identified a panel of proteins linked to early development of pancreatic cancer in mice that applies also to early stages of the disease in humans - a breakthrough that brings scientists a significant step closer to developing a blood test to detect the disease early, when cure rates are highest.
EUREKA project E! 3172 NKSTIM has produced a new potential drug to stimulate cancer patients' own 'natural killer' cells to attack and eliminate cancer cells; currently undergoing clinical testing in patients with leukaemia or myeloma.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Robert Coleman, MD Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | John Robert Coleman, MD 1204 W Main St, Charlottesville, VA 22903-2824 Ph: (434) 982-6100 |
News Archive
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, editor Amie Newman, a communications officer at the foundation, highlights the work of "two HIV home-visit health workers who work with the CDC Kenya (Centers for Disease Control) to visit with a family in a remote area in the Nyanza province."
The RAND Corporation today launched an online tool to provide policymakers and interested parties with a unique way of understanding and evaluating the effects and unintended consequences of health care reform proposals certain to be introduced in the new 111th Congress and beyond.
Ethicon, Inc., announced today that it has completed the acquisition of Acclarent, Inc., following clearance under the Hart-Scott-Rodino Antitrust Improvement Act. Acclarent is a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT).
A multicenter team of researchers has identified a panel of proteins linked to early development of pancreatic cancer in mice that applies also to early stages of the disease in humans - a breakthrough that brings scientists a significant step closer to developing a blood test to detect the disease early, when cure rates are highest.
EUREKA project E! 3172 NKSTIM has produced a new potential drug to stimulate cancer patients' own 'natural killer' cells to attack and eliminate cancer cells; currently undergoing clinical testing in patients with leukaemia or myeloma.
› Verified 2 days ago
Farnaz M Gazoni, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Katherine T, Forkin, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Edward C. Nemergut, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Allison J. Bechtel, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Kristi Hackworth Rose, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2331 Seminole Ln Ste 201, Charlottesville, VA 22901 Phone: 434-293-4995 Fax: 434-971-3434 | |
Sunny S. Chiao, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-2283 Fax: 434-982-0019 | |
Logan David Kinch, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 545 Ray C Hunt Dr Ste 316, Charlottesville, VA 22903 Phone: 434-243-5676 Fax: 434-243-5689 |